Skip to main content
. Author manuscript; available in PMC: 2024 Mar 18.
Published in final edited form as: Int J Infect Dis. 2022 Apr 30;121:92–97. doi: 10.1016/j.ijid.2022.04.060

Table 1.

Test positivity rate among patients presenting with febrile illness, by test, among samples with results available

Test Results available (N) Positivity % (95% CI)
RDT 496 67.3% (63.0–71.5
HRP2 antigenemia 496 81.9% (78.2–85.2)
Blood smear 298 61.4% (55.6–67.0)
PET-PCR 284 68.7% (62.9–74.0)
≥ 1 long half-life antibody + 494 89.4% (86.6–92.0)
≥ 1 short half-life antibody + 494 80.6% (77.1–84.1)